EBI Fixed Income

Earn an 11% return p.a. over two years with EBI Fixed Income

At Ethical Bioscience Investments, we offer high-yield, fixed income opportunities for sophisticated investors looking to invest across the global bioscience sector.

As we enter historically low interest rate environments, there’s never been a better time to achieve regular, high-yield financial returns while positively impacting the future of global healthcare.

With our EBI Fixed Income product, investors can now take advantage of our global portfolio of diversified investments across the biotechnology sector, carefully selected and validated by our Scientific Advisory Board and Investment Committee.

COUPON RATE (P.A.) 7% 9% 11%
INVESTMENT TERM 6 months 12 months 24 months
^These rates are exclusively available for sophisticated investors investing in EBI Fixed Income.
COUPON RATE (P.A.) INVESTMENT TERM
7% 6 months
9% 12 months
11% 24 months
^These rates are exclusively available for sophisticated investors investing in EBI Fixed Income.

Request Further Information

For further information and to receive a copy of our brochure, please complete the form below.
  • This field is for validation purposes and should be left unchanged.

EBI Fixed Income Calculator

Investment Amount

AU $

Investment Term

Interest Rate

7% PA

TOTAL INTEREST EARNED OVER 6 Month TERM

AU $3,500

Quarterly DISTRIBUTION

AU $1,750

Why Invest With EBI?

NO MANAGEMENT, SET UP OR HIDDEN FEES

OPPORTUNITY TO INVEST IN ROBUST GLOBAL BIOSCIENCE SECTOR

INVEST IN PRODUCTS VETTED BY TRUSTED EXPERTS

ACCELERATE THE DEVELOPMENT OF FUTURE MEDICINES

Investment Philosophy

At Ethical Bioscience Investments, with advisory from our Scientific Advisory Board and our Investment Committee, we only approve investments in ventures with a clear competitive advantage.

Our investment doctrine stems from our validation trinity: Science, People, Financials.

Science: When considering investment proposals, we validate:

  • The scientific merit of an innovation;
  • The viability of the proposed development plan;
  • The intellectual property (IP) position; and
  • The IP portfolio structure.

We constantly monitor the execution of the research and development, ensuring that pre-defined milestones are being met. Furthermore, our dedicated Scientific Advisory Board, together with a specialised clinical research and development company, oversees the entire research and development process of the investee entities. Therefore, as an active investor throughout the entire research and development cycle, we have the unique capability to identify and map scientific milestones, which we translate into value creation events, triggering divestment opportunities.

People: We acknowledge that it takes great people to create and sustain great companies. We seek proof that the leaders of investee companies have the will, capability and capacity to realise the proposed research and development. Additionally, we ascertain they can efficiently apply corporate governance and best management principles to the everyday operations of the company.

Financials: We select investment opportunities based on strict evaluation criteria that analyses fundamental financial value and performance, such as each issuer’s financial and industry position, as well as market and economic conditions. We then look at these factors through the unique lens of the biopharmaceutical, life science and healthcare sectors to ensure maximum value realisation.

The Bioscience Sector

With global healthcare under unprecedented pressure, innovation must accelerate like never before.

Population increase, rising life expectancy, urbanisation and the spread of infectious diseases demand a new frontier for bioscience innovation to ensure the right medicines are developed when the world needs them most.

At Ethical Bioscience Investments, we invest across the entire bioscience sector – from chemical, biologic, genetic pharmaceutical interventions, to advanced point of care diagnostics, medicine nanorobotics, all at the forefront of medical research.

Expert Leadership

At Ethical Bioscience Investments, our leadership draws on a robust breadth of expertise across medicine, investment banking, corporate advisory, drug development, biopharmaceuticals and scientific innovation.

Contact Us

Please complete the form and a member of the EBI team will contact you shortly to assist with your enquiry.
  • This field is for validation purposes and should be left unchanged.